Biolase (Nasdaq:BIOL) announced today that it appointed Jennifer Bright as its new CFO and Steven Sandor as its new COO. Lake Forest, California-based Biolase — a developer of laser technologies for the dental space — made the promotions of both executives effective immediately. Both will report to Biolase President and CEO John Beaver. Bright has […]
Biolase
FDA clears Biolase’s laser-assisted microfluidic irrigation device
Biolase (NSDQ:BIOL) and EdgeEndo announced today that the FDA granted 510(k) clearance to the EdgePRO system. EdgePRO offers endodontists a cleaning and disinfection alternative within root canal procedures as a laser-assisted, microfluidic irrigation device. Biolase built the EdgePRO platform upon its patented laser technology for debridement, cleaning and disinfection through the removal of infected tissue, […]
Biolase names new president and CEO
Biolase (NSDQ:BIOL) today announced that it has appointed John Beaver as president and CEO, effective immediately. Beaver replaces Todd Norbe, who has served as president and CEO since August 2018. Beaver previously served as the company’s executive VP, chief operating officer and chief financial officer. “John’s knowledge of the dental industry, combined with his executive management […]
Biolase enters into securities purchase agreement for $6.9m
Biolase (NSDQ:BIOL) announced today that it entered into a securities purchase agreement expected to produce gross proceeds of approximately $6.9 million. The purchase agreement with certain accredited institutional investors includes a registered direct offering and concurrent private placement with 10.8 million shares of Biolase’s common stock and warrants o purchase 10.8 million shares of the common […]
Biolase lands 510(k) for dental hygiene laser
Biolase (NSDQ:BIOL) this week announced it has received FDA 510(k) clearance for its Epic Hygiene dental laser. The laser system allows dental hygienists to manage non-surgical periodontitis and increase clinical production. It offers a step-by-step clinical protocol with pocket therapy and perio debridement for easy implementation. “We were thrilled to announce the launch of the Epic […]
Biolase beats Street despite Q3 losses
Biolase (NSDQ:BIOL) shares hit a slight uptick on third-quarter results that topped the consensus forecast in spite of revenue and profit dips. The Irvine, Calif.-based laser system developer earlier this month posted losses of -$5.5 million, or -25¢ per share, on sales of $8.6 million for the three months ended Sept. 30, for a 17.4% bottom-line […]
Biolase prices $9m offering
Biolase (NSDQ:BIOL) has priced an underwritten public offering of its common stock worth approximately $8.5 million. The offering, priced yesterday, includes more than 7.8 million shares of common stock at about 58¢ per share, plus a 30-day over-allotment option for the additional purchase of up to nearly 1.2 million shares at the public offering price. The […]
Biolase, CAO Group settle laser patent spat
Biolase (NSDQ:BIOL) said late last month that it reached a settlement deal with CAO Group to end a patent infringement suit the companies were engaged in over laser technologies, according to an SEC filing. Irvine, Calif.-based Biolase said that CAO agreed to dismiss with prejudice lawsuits it filed against Biolase in April 2012 and again in January 2018 […]
Fujifilm Sonosite taps Ueda as chair, CEO | Personnel Moves – August 9, 2018
Fujifilm‘s (TSE:4901) SonoSite subsidiary said earlier this week it appointed Fujifilm vet and current Fujifilm Medical Systems USA and Fujifilm New Development USA prez Takaaki Ueda as its new chair and CEO. Previously, Ueda has also served as Fujifilm global endoscopy systems division GM, the company said. Ueda will replace the departing Masayuki Higuchi who […]
Biolase initiates 1-for-5 reverse stock split
Biolase (NSDQ:BIOL) said today it initiated a 1-for-5 reverse split of its stock, slated to take effect at the opening of the market tomorrow. With the split, the Irvine, Calif.-based company will put a single share of its common stock in the hands of each of its shareholders for every five shares they previously owned, according […]
Biolase CEO Flynn steps down | Personnel Moves – April 13, 2018
Biolase (NSDQ:BIOL) said this week its CEO Harold Flynn has resigned from the company to pursue other interests, and that current CFO John Beaver will step in to act as interim CEO. The transition will be made immediately, the Irvine, Calif.-based company said. “I would like to thank Harold for the leadership and commitment he has […]